The overall goal of this program is to utilize immunologic, molecular, and synthetic approaches to develop means for treating AIDS and controlling HIV infection. The specific approaches to be employed include: 1) generation of HIV specific cytolytic T lymphocyte clones and investigation of the potential for using such clones in adoptive cellular immunotherapy, 2) detailed studies of the interactions between viral envelope glycoprotein and CD4 determinants critically involved in the pathobiology of HIV infection, using synthetic peptide and recombinant DNA approaches to identify and develop therapeutic agents capable of interrupting these crucial interactions between the viral envelope and CD4, 3) production and functional characterization of mouse/human chimeric antibodies and immunotoxin conjugates for selective targeting and destruction of infected cells expressing HIV antigens, and 4) generation of HIV- derived vectors and a viral packaging line for selective targeting and expression of defined genetic sequences to effect blockade of HIV replication and/or removal of HIV infected cells from the host. This multidisciplinary approach involves scientists at three institutions and takes advantage of the special areas of expertise of the Program Leaders and of technical resources already well established in our laboratories, and is based on extensive ongoing collaborative interactions between the Program Leaders. In addition, the research program outlined in this proposal incorporates approaches directed against several distinct phases of the viral life cycle with the ultimate goal of developing a synergistic, multimodal approach of the type that will probably be ultimately required for effective therapy of HIV infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI025922-04
Application #
3546963
Study Section
Special Emphasis Panel (SRC (49))
Project Start
1987-09-30
Project End
1992-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Piatak Jr, M; Saag, M S; Yang, L C et al. (1993) Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS 7 Suppl 2:S65-71
Piatak Jr, M; Luk, K C; Williams, B et al. (1993) Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 14:70-81
Lifson, J D (1993) Fusion of human immunodeficiency virus-infected cells with uninfected cells. Methods Enzymol 221:3-12
Piatak Jr, M; Saag, M S; Yang, L C et al. (1993) High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-54
Eiden, L E; Lifson, J D (1992) HIV interactions with CD4: a continuum of conformations and consequences. Immunol Today 13:201-6
Ruegg, C L; Rajasekar, S; Stein, B S et al. (1992) Degradation of CD4 following phorbol-induced internalization in human T lymphocytes. Evidence for distinct endocytic routing of CD4 and CD3. J Biol Chem 267:18837-43
Mohagheghpour, N; Chakrabarti, R; Stein, B S et al. (1991) Early activation events render T cells susceptible to HIV-1-induced syncytia formation. Role of protein kinase C. J Biol Chem 266:7233-8
Suzuki, T; Suzuki, N; Daynes, R A et al. (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 61:202-11
Berger, E A; Lifson, J D; Eiden, L E (1991) Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in m Proc Natl Acad Sci U S A 88:8082-6
Lifson, J D; Rausch, D M; Kalyanaraman, V S et al. (1991) Synthetic peptides allow discrimination of structural features of CD4(81-92) important for HIV-1 infection versus HIV-1-induced syncytium formation. AIDS Res Hum Retroviruses 7:521-7

Showing the most recent 10 out of 24 publications